
    
      Ursodeoxycholic acid (URSA) is known to be relatively safe and beneficial in peritoneal
      dialysis patient at a dose of 300 mg per day. Patients will be randomly assigned to URSA and
      placebo group and prescribed according to the protocol. At 2 and 6 month, Peritoneal
      equilibrium test (PET) will be performed with blood sampling.
    
  